SecBot SecBot
Insider Cluster (2 insiders) ·Filed Oct 1, 2026

RAPP

Rapport Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed24d 14h ago
Insider cluster: 2 insiders, $270K total
Actionable Insight • Neutral

The small CEO sale is likely liquidity-driven, and the COO's larger sale may be part of a pre-arranged plan. Monitor next 10-Q for any operational changes or guidance shifts that could explain insider selling.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+5d
RAPP ▼ -4.72% at T+5d
NEUTRAL call ✗ call lost -4.72% · α vs SPY -5.89% · entry $32.17 → $30.65
Next anchor: T+20d in 3d
Latest observation: T+15 -13.16% FF3 residual α
Entry anchored
Oct 1, 04:23 PM ET
via 1-min bar
T+1d
+0.06%
call +0.06% · α -0.61%
$32.19
settled 24d ago
T+5d
-4.72%
call -4.72% · α -5.89%
$30.65
settled 18d ago
T+20d
Pending
in 3d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Two insiders at Rapport Therapeutics sold a total of $270K in shares over a one-week window in late September 2026. The CEO sold a small amount ($9K), while the COO sold a larger block ($262K) at a lower price. The total value is ~0.08% of the company's $326M market cap, falling below the 0.1% materiality threshold, and the COO's sale may be routine or plan-driven. This cluster is not a strong directional signal.

Key Financial Metrics

Direction
selling
Total Value
$270.0K
Insiders
2

Key Facts

  • CEO Ceesay Abraham sold 215 shares for ~$9K on 2026-09-23.
  • COO Cheryl Gault sold 7,900 shares for ~$262K on 2026-09-30.
  • Total insider sales of $270K represent ~0.08% of RAPP's $326M market cap.
  • No open-market purchases were reported in this cluster.
  • The COO's sale is the dominant transaction by value but may be routine or 10b5-1 plan-driven.

Financial Impact

Total insider sales of $270K, or ~0.08% of market cap — trivial relative to company size.

insider ownershipfloat

Risk Factors

  • Insider selling, even at low levels, can precede negative news if unplanned.
  • The COO's sale at a lower price than the CEO's may indicate a lack of confidence, though the absolute dollar amount is small.

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RAPP-1790886659880
22 reports for RAPP
Performance horizon
67% Hit rate @ T+5 4 of 6 directional calls Went positive at some point 6 of 8 best @ T+60▲ +24.87%Mar 10, 2026
Filters
Rows
Reports for RAPP — sortable, filterable
TypeNow
Oct 23, 2026
2d ago
Insider Cluster
BULLISH ★ 5/10
$26.00awaiting T+5—$25.93 (−0.27%)
Oct 22, 2026
4d ago
Insider Cluster
BULLISH ★ 5/10
$27.33awaiting T+5—$25.93 (−5.12%)
Oct 21, 2026
4d ago
Insider Buy
BULLISH ★ 4/10
$26.53awaiting T+5—$25.93 (−2.26%)
Oct 20, 2026
6d ago
8-K
BULLISH ★ 7/10
$29.37awaiting T+5—$25.93 (−11.71%)
Oct 6, 2026
19d ago
144
BEARISH ★ 5/10
$30.86 $28.33▲ +8.20%▲ +7.22%$25.93 (+15.98%)
Oct 1, 2026
24d ago
Insider Cluster
NEUTRAL ★ 3/10
$32.17 $30.65▼ −4.72%▼ −5.89%$25.93 (−19.40%)
Aug 26, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$50.83 $47.65▼ −6.26%▼ −6.52%$25.93 (−48.99%)
Aug 5, 2026
11w ago
8-K
MIXED ★ 5/10
$42.44 $47.73▲ +12.46%▲ +12.11%$25.93 (−38.90%)
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$38.97 $41.75▲ +7.13%▲ +5.77%$25.93 (−33.46%)
Jun 30, 2026
16w ago
144
NEUTRAL ★ 2/10
$39.39 $39.72▲ +0.84%▲ +0.58%$25.93 (−34.17%)
Showing 10 of 22

US Market Status

Market Closed — Opens in 2h 44m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 1, 2026